PharmaLedger Association reports that FDA and EMA released joint AI governance principles.

The PharmaLedger Association (PLA) is a not-for-profit with global reach founded in 2022 as the result of the successful completion of the IMI PharmaLedger public-private consortium (2020-2022). PLA’s core objective is to implement and promote a Digital Trust Ecosystem in Healthcare (DTE-H). PLA is a neutral party, pre-competition organization capable of ensuring continuous adherence to antitrust, intellectual property, data privacy, and Computerized System Assurance guidelines. Why is PLA needed? To solve ecosystem-wide problems that cannot be solved by silos or single organizations. It takes an ecosystem to sustain a trusted, shared infrastructure for secure data exchange in healthcare. Any organization or company connected and impacted by the healthcare industry can become a member of PLA, including manufacturers, wholesalers, distributors, pharmacy chains, clinics, hospitals, technology and other specialized service providers, healthcare organizations, NGOs, and patient organizations, among others. Our associated organizations have the opportunity to pool resources, share risks and be an at the forefront of the creation of the modern healthcare experience, Healthcare 4.0 is here! Join us and learn more at: https://pharmaledger.org/

Founded 2022